Name (Synonyms) | Correlation | |
---|---|---|
drug1998 | REGN10933+REGN10987 combination therapy Wiki | 0.71 |
drug1822 | Placebo Wiki | 0.06 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Prospective interventional study, single arm of purified convalescent plasma transfusion as an add on therapy for the standard of care treatment (national guideline) (Oseltamivir (75mg/12 hours for 5-10 days) and hydroxychroquine (400mg twice in first day, 200 twice for 4-9 days) ± Azithromycin 500mg daily for 5 days
Description: Two successive negative COVID-19 PCR analysis tests 72 hours apart
Measure: viral COVID-19 clearance Time: 14 daysDescription: The percentage of decrease of radiological abnormalities at day 14
Measure: Decrease of radiological abnormalities Time: 14 daysDescription: Clinical improvement in form of normal body temperature for 48 hours
Measure: Clinical improvement Time: 14 days